Top Stories
-
2 days ago
Pharmaxis' PXS-5505 doubles response rate to standard therapy in blood cancer in preclinical studies; features in prestigious journal
proactiveinvestors.com
-
4 days ago
AION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications: Developing Molecular Glues
finance.yahoo.com
-
4 days ago
AION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications: Developing Molecular Glues
benzinga.com
-
A week ago
Cancer Specialty Treatment: New Energy for Particle Therapy
worldheraldnews.com
-
A week ago
The work of the Felix Burda Foundation is now even more important-breakinglatest.news-Breaking Latest News
breakinglatest.news
-
A week ago
Lack of coordination between neural assemblies of key brain regions cause memory loss: Study
news9live.com
-
A week ago
Lack of coordination between neural assemblies of key brain regions causes memory loss: Study
tribuneindia.com
-
A week ago
Affimed Announces Presentations of Clinical Data from AFM13 Phase 2 REDIRECT and Pre-clinical Data Demonstrating CD16A Shedding Facilitates Repetitive Targeting of Tumor Cells by AFM13-armed NK Cells at the Annual Meeting of the American Association for Cancer Research
finance.yahoo.com
-
2 weeks ago
Doctors thought it was stress – then Mollie (24) gets a shock diagnosis of cancer-breakinglatest.news-Breaking Latest News
breakinglatest.news